August 11, 2020

Adecto Pharmaceuticals president Dr. Gail Sonenshein receives Tufts University School of Medicine 2020 Zucker Award for outstanding career achievements in women's health research



May 24, 2019

Adecto Pharmaceuticals awarded Phase I NCI SBIR grant for development of ADAM8 cancer diagnostic



October 22, 2018

Adecto Pharmaceuticals awarded multimillion-dollar NCI SBIR grant to continue development of ADAM8 targeted therapy



March 1, 2018

Adecto Pharmaceuticals selected to participate in MassBio’s MassCONNECT mentoring program



April 2, 2017

Adecto Pharmaceuticals presents poster on selection of lead candidate therapeutic antibodies at the 2017 AACR annual meeting



April 15, 2016

Adecto Pharmaceuticals awarded Phase I NCI STTR grant for the development of ADAM8 targeted therapies



April 13, 2015

Adecto Pharmaceuticals wins Tufts $100K New Ventures Competition



March 18, 2014

New Hope for Tough-to-Treat Breast Cancers

Tufts researchers find promising target in battle against aggressive tumors